Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Iliopoulos-Tsoutsouvas

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|September 26, 2018
Fluorescent probes for G-protein-coupled receptor drug discoveryChristos Iliopoulos-Tsoutsouvas, Rohit N Kulkarni, Alexandros Makriyannis, et al.
Behavioural Pharmacology|March 15, 2022
Evidence for spontaneous cannabinoid withdrawal in miceCarol Paronis, Christos Iliopoulos-Tsoutsouvas, Ioannis Papanastasiou, et al.
Neuropharmacology|February 25, 2026
Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ9-Tetrahydrocannabinol, AM11101, and AM8936Evan C Smith, Christos Iliopoulos-Tsoutsouvas, Markos Georgiadis, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Molecular Pharmacology|September 24, 2022
Differential Enantiomer-Specific Signaling of Cannabidiol at CB<sub>1</sub> ReceptorsTaryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, et al.
Behavioural Pharmacology|March 15, 2022
Altered sleep during spontaneous cannabinoid withdrawal in male miceGalen Missig, Niyati Mehta, James O Robbins, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Receptors (Basel, Switzerland)|May 16, 2025
Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site MutationsChristina A Brust, Matthew A Swanson, Christos Iliopoulos Tsoutsouvas, et al.
Research Square|June 3, 2024
Structural basis of Δ<sup>9</sup>-THC analog activity at the Cannabinoid 1 receptorDavid Gloriam, Thor Thorsen, Yashraj Kulkarni, et al.
European Journal of Medicinal Chemistry|January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonistsIoannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|September 26, 2018
Fluorescent probes for G-protein-coupled receptor drug discoveryChristos Iliopoulos-Tsoutsouvas, Rohit N Kulkarni, Alexandros Makriyannis, et al.
Behavioural Pharmacology|March 15, 2022
Evidence for spontaneous cannabinoid withdrawal in miceCarol Paronis, Christos Iliopoulos-Tsoutsouvas, Ioannis Papanastasiou, et al.
Neuropharmacology|February 25, 2026
Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ9-Tetrahydrocannabinol, AM11101, and AM8936Evan C Smith, Christos Iliopoulos-Tsoutsouvas, Markos Georgiadis, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Molecular Pharmacology|September 24, 2022
Differential Enantiomer-Specific Signaling of Cannabidiol at CB<sub>1</sub> ReceptorsTaryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, et al.
Behavioural Pharmacology|March 15, 2022
Altered sleep during spontaneous cannabinoid withdrawal in male miceGalen Missig, Niyati Mehta, James O Robbins, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Receptors (Basel, Switzerland)|May 16, 2025
Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site MutationsChristina A Brust, Matthew A Swanson, Christos Iliopoulos Tsoutsouvas, et al.
Research Square|June 3, 2024
Structural basis of Δ<sup>9</sup>-THC analog activity at the Cannabinoid 1 receptorDavid Gloriam, Thor Thorsen, Yashraj Kulkarni, et al.
European Journal of Medicinal Chemistry|January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonistsIoannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Pageof 2